Company profile: ANI Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of pharmaceutical manufacturing and packaging services for solid and liquid dosage forms, including tablets, capsules, solutions, suspensions, lotions, and ointments, with immediate and modified release capabilities, containment handling, and contract packaging with quality control and stability support; marketer of generic products and the branded Purified Cortrophin Gel.
Products and services
- Generic Pharmaceuticals: Multi-therapeutic portfolio marketing a wide range of generic tablets, capsules, and oral suspensions covering various therapeutic areas
- Purified Cortrophin® Gel: Corticosteroid-based branded pharmaceutical indicated for certain chronic conditions requiring corticosteroid therapy, formulated as a gel dosage form
- Solid Dose Manufacturing / Packaging: Oral-solid–focused manufacturing and packaging for tablets and capsules, with capabilities for immediate and modified release forms
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ANI Pharmaceuticals
PharmaSeek
HQ: United States
Website
- Description: Provider of consulting and training solutions for clinical research sites, helping institutions, investigators, and independent sites decrease study start-up timelines by assuming administrative burdens of research management, including study identification, contract and budget negotiation, coverage analysis, and financial management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaSeek company profile →
BioStrata
HQ: United Kingdom
Website
- Description: Provider of life science marketing services delivered by a team fluent in scientific and business languages, including brand awareness, lead generation and customer conversion; scientific and technical content creation; SEO (keyword research, content optimization, performance tracking); public relations; and marketing strategy development based on market research and tactical planning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioStrata company profile →
PCAS
HQ: France
Website
- Description: Provider of technology-oriented fine chemical development and production services, specializing in processes and complex molecule manufacturing for Life Sciences and Specialty Chemicals markets. Serving global industrial customers since 1962, with a focus on safety, reliability, and compliance with sustainable development, ISO, and GMP regulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PCAS company profile →
Noble Pharma
HQ: United States
Website
- Description: Provider of FDA-approved contract development and manufacturing services for extremely palatable animal health products, including formulation and process development; manufacturing of soft chews, creams, ointments, suspensions, tablets, powders, and pastes; clinical supplies; GLP analytical and ICH stability services; regulatory support; packaging with serialization and child-resistant options; and technology transfer and validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noble Pharma company profile →
Ergomed
HQ: United Kingdom
Website
- Description: Provider of specialized services to the pharmaceutical industry and the development of new drugs, operating two complementary businesses, including a well-established clinical research business providing services to the pharmaceutical and biotechnology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ergomed company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ANI Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ANI Pharmaceuticals
2.2 - Growth funds investing in similar companies to ANI Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ANI Pharmaceuticals
4.2 - Public trading comparable groups for ANI Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →